Stay updated on IGN002 Dose-Escalation Study in NHL Clinical Trial
Sign up to get notified when there's something new on the IGN002 Dose-Escalation Study in NHL Clinical Trial page.

Latest updates to the IGN002 Dose-Escalation Study in NHL Clinical Trial page
- Check3 days agoChange DetectedNotice about government funding and operating status was removed from the page; the rest of the study details remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedThe page has a redesigned layout and styling, but core study details such as title, conditions, eligibility, outcomes, and locations remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check46 days agoChange Detected- Added a government-operations notice about potential delays and updated status; included links for details. - Updated software version from v3.1.0 to v3.2.0.SummaryDifference5%

- Check53 days agoChange Detected- Updated version from v3.0.2 to v3.1.0. - No other content changes detected.SummaryDifference0.1%

- Check67 days agoChange DetectedVersion updated from v3.0.1 to v3.0.2; the Back to Top link was removed. No other substantive changes detected.SummaryDifference0.3%

- Check74 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. Additionally, a 'Back to Top' feature has been added for improved navigation.SummaryDifference0.3%

Stay in the know with updates to IGN002 Dose-Escalation Study in NHL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IGN002 Dose-Escalation Study in NHL Clinical Trial page.